Page last updated: 2024-09-03

mdl-201112 and dinoprostone

mdl-201112 has been researched along with dinoprostone in 1 studies

Compound Research Comparison

Studies
(mdl-201112)
Trials
(mdl-201112)
Recent Studies (post-2010)
(mdl-201112)
Studies
(dinoprostone)
Trials
(dinoprostone)
Recent Studies (post-2010) (dinoprostone)
100029,1051,3466,357

Protein Interaction Comparison

ProteinTaxonomymdl-201112 (IC50)dinoprostone (IC50)
Prostaglandin E2 receptor EP1 subtypeHomo sapiens (human)0.0155
Prostaglandin E2 receptor EP4 subtypeHomo sapiens (human)0.0031
Prostaglandin E2 receptor EP4 subtypeRattus norvegicus (Norway rat)0.0021
Prostaglandin E2 receptor EP3 subtypeHomo sapiens (human)0.002
Prostaglandin E2 receptor EP2 subtypeHomo sapiens (human)0.0087
Prostacyclin receptorHomo sapiens (human)0.26
Prostaglandin E2 receptor EP2 subtypeRattus norvegicus (Norway rat)0.0052

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Humidan, A; Al-Sedairy, ST; Al-Sofi, A; Dzimiri, M; Edwards, CK; Khabar, KS1

Other Studies

1 other study(ies) available for mdl-201112 and dinoprostone

ArticleYear
A carbocyclic nucleoside analogue is a TNF-alpha inhibitor with immunosuppressive action: role of prostaglandin E2 and protein kinase C and comparison with pentoxifylline.
    Cellular immunology, 1998, Aug-25, Volume: 188, Issue:1

    Topics: Adenine; Dinoprostone; Humans; Immunosuppressive Agents; Interleukin-8; Isoantigens; Leukocytes, Mononuclear; Lymphocyte Culture Test, Mixed; Pentoxifylline; Phosphodiesterase Inhibitors; Protein Kinase C; Superantigens; T-Lymphocytes; Tumor Necrosis Factor-alpha

1998